en English
af Afrikaanssq Shqipam አማርኛar العربيةhy Հայերենaz Azərbaycan dilieu Euskarabe Беларуская моваbn বাংলাbs Bosanskibg Българскиca Catalàceb Cebuanony Chichewazh-CN 简体中文zh-TW 繁體中文co Corsuhr Hrvatskics Čeština‎da Dansknl Nederlandsen Englisheo Esperantoet Eestitl Filipinofi Suomifr Françaisfy Fryskgl Galegoka ქართულიde Deutschel Ελληνικάgu ગુજરાતીht Kreyol ayisyenha Harshen Hausahaw Ōlelo Hawaiʻiiw עִבְרִיתhi हिन्दीhmn Hmonghu Magyaris Íslenskaig Igboid Bahasa Indonesiaga Gaeligeit Italianoja 日本語jw Basa Jawakn ಕನ್ನಡkk Қазақ тіліkm ភាសាខ្មែរko 한국어ku كوردی‎ky Кыргызчаlo ພາສາລາວla Latinlv Latviešu valodalt Lietuvių kalbalb Lëtzebuergeschmk Македонски јазикmg Malagasyms Bahasa Melayuml മലയാളംmt Maltesemi Te Reo Māorimr मराठीmn Монголmy ဗမာစာne नेपालीno Norsk bokmålps پښتوfa فارسیpl Polskipt Portuguêspa ਪੰਜਾਬੀro Românăru Русскийsm Samoangd Gàidhligsr Српски језикst Sesothosn Shonasd سنڌيsi සිංහලsk Slovenčinasl Slovenščinaso Afsoomaalies Españolsu Basa Sundasw Kiswahilisv Svenskatg Тоҷикӣta தமிழ்te తెలుగుth ไทยtr Türkçeuk Українськаur اردوuz O‘zbekchavi Tiếng Việtcy Cymraegxh isiXhosayi יידישyo Yorùbázu Zulu
Hypofractionated Radiation Therapy for Prostate Cancer

 

As the COVID-19 pandemic continues, many cancer patients are having to make the difficult decision to continue with their current cancer regimen or delay treatments.  Cancer patients and physicians must carefully weigh the potential benefit of routine cancer care versus the risk of COVID-19. To help ease these decisions, several peer-reviewed, non-profit cancer care organizations […]

 

Learn More

 

 

Prostate Cancer Treatment and Sexual Function

 

When deciding which treatment option is best for their prostate cancer, men take numerous factors into consideration.  While their physician’s recommendation does play an important role in the treatment decision, in the end, most men make the choice that is best for them.  That choice is often based on treatment outcomes and side effects, and […]

 

Learn More

 

 

Studies Show CyberKnife Provides Excellent Prostate Cancer Survival Rates in Five or Fewer Sessions

 

Accuray Incorporated, developer and manufacturer of the CyberKnife® System, announced that published data from two multicenter studies using differing protocols provide consistent results and reinforce the use of the CyberKnife system for the effective management of low-and intermediate-risk prostate cancer.  The studies are the largest conducted to date evaluating stereotactic body radiation therapy (SBRT) in […]

 

Learn More

 

 

Veterans and Prostate Cancer

 

 

Learn More

 

 

American Urological Association, American Society for Radiation Oncology, and the Society of Urologic Oncology Release Joint Prostate Cancer Guidelines

 

Last week, the American Urological Association (AUA), the American Society for Radiation Oncology (ASTRO), and the Society of Urologic Oncology (SUO) released collaborative clinical guidelines for managing localized prostate cancer which offers a framework for shared decision-making between physicians and patients.  Through this collaboration, the committee provided guidance on active surveillance and on which treatments […]

 

Learn More

 

 

The U.S. Preventive Services Task Force Updates Screening Guidelines for Prostate Cancer

 

The U.S. Preventive Services Task Force (USPSTF) recently updated their prostate screening recommendations. On April 11, 2017, the USPSTF issued an updated draft recommendation on screening for prostate cancer.  The updated recommendation changes the grade for PSA-based screening from “D” to “C” for men 55 – 69 years of age.  As a result, the USPSTF […]

 

Learn More

 

 

Dr. Heuser’s CyberKnife Story

 

Watch general surgeon, Dr. Louis Heuser, talk about why he chose CyberKnife for the treatment of his prostate cancer. Dr. Heuser was very happy with the quick treatments and the fact that he was able to stay close to home and continue to work and see his patients. It’s Your Prostate, Your Cancer, Your Choice.

 

Learn More

 

 

CyberKnife System Provides Long-term Disease Control for Prostate Cancer Patients

 

Accuray Incorporated, the manufacturer of the CyberKnife® Robotic Radiosurgery System, recently announced data from a study which showed that treatment with the CyberKnife System for low and intermediate risk prostate cancer provides excellent long-term results. The seventeen center study, which was presented last month at the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO […]

 

Learn More

 

 

Early Diagnosis: These Five Cancer Screenings Are Recommended

 

One of the ways you can reduce your risk for cancer is by getting screening tests that can help find cancer at an early stage, before symptoms appear. When abnormal tissue or cancer is found early, it may be easier to treat or cure.  By the time symptoms appear, the cancer may have grown and […]

 

Learn More

 

 

Stereotactic Body Radiation Therapy Shows 98 Percent Prostate Cancer Cure

 

According to researchers at UT Southwestern Medical Center Harold C. Simmons Comprehensive Cancer Center, a five-year study shows that stereotactic body radiation therapy (SBRT) offers a higher cure rate for prostate cancer than more traditional approaches.  The study, the first trial to publish five-year results from SBRT treatment for prostate cancer, found a 98.6 percent […]

 

Learn More